Johns Hopkins Psychiatry Guide
Ziprasidone
INDICATIONS
FDA
FDA
- Schizophrenia
- Mixed or manic episodes in bipolar I disorder as monotherapy
- Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate
- Acute treatment of agitation in adults with schizophrenia (IM)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Management of delirium
- Adjunct to antidepressants in treating major depressive disorder
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 24, 2025
Citation
Qureshi, Imran. "Ziprasidone." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787508/9/Ziprasidone.
Qureshi I. Ziprasidone. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787508/9/Ziprasidone. Accessed October 30, 2025.
Qureshi, I. (2025). Ziprasidone. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787508/9/Ziprasidone
Qureshi I. Ziprasidone [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787508/9/Ziprasidone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ziprasidone
ID - 787508
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/08/24/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787508/9/Ziprasidone
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
